Log in
NYSE:BHVN

Biohaven Pharmaceutical Earnings Date, Estimates & History

$78.47
+0.89 (+1.15 %)
(As of 10/29/2020 12:00 AM ET)
Add
Compare
Today's Range
$75.74
Now: $78.47
$78.60
50-Day Range
$59.04
MA: $69.56
$79.77
52-Week Range
$26.56
Now: $78.47
$80.00
Volume476,346 shs
Average Volume791,994 shs
Market Capitalization$4.68 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.19

Earnings

Biohaven Pharmaceutical (NYSE:BHVN) Earnings Information

Biohaven Pharmaceutical last issued its earnings data on August 10th, 2020. The reported ($2.55) EPS for the quarter, topping the consensus estimate of ($2.78) by $0.23. The company had revenue of $9.70 million for the quarter, compared to the consensus estimate of $7.43 million. Biohaven Pharmaceutical has generated ($10.91) earnings per share over the last year. Biohaven Pharmaceutical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 6th, 2020 based off prior year's report dates.

Biohaven Pharmaceutical Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Biohaven Pharmaceutical (NYSE:BHVN) Earnings Estimates

2020 EPS Consensus Estimate: ($8.22)
2021 EPS Consensus Estimate: ($7.10)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20204($2.80)($1.35)($1.99)
Q2 20204($2.74)($1.30)($1.92)
Q3 20205($3.04)($1.40)($2.36)
Q4 20205($3.04)($0.85)($1.96)
Q1 20214($2.75)($1.28)($2.01)
Q2 20214($2.65)($1.16)($1.87)
Q3 20214($2.60)($0.67)($1.67)
Q4 20213($2.50)($0.16)($1.55)

Biohaven Pharmaceutical (NYSE BHVN) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/6/2020
(Estimated)
       
8/10/20206/30/2020($2.78)($2.55)($2.02)$7.43 million$9.70 millionTranscript
5/7/2020Q1($2.46)($2.39)($1.71)$0.21 million$1.10 millionN/A
2/25/2020Q4($1.91)($2.85)($2.85)N/A
11/1/2019Q3 2019($1.57)($2.04)($2.04)N/A
8/8/2019Q2($2.09)($2.35)($0.03)N/A
5/7/20193/31/2019($1.50)($1.41)($1.41)N/A
2/28/2019Q4 2018($1.28)($1.34)($1.34)N/A
11/14/20189/30/2018($1.05)($1.53)($1.53)N/A
8/14/2018Q2 2018($1.68)($1.01)($1.01)N/A
5/15/2018Q1 2018($1.1150)($2.32)($2.32)N/A
3/6/2018Q4 2017($1.33)($0.75)($0.75)N/A
11/14/2017Q3 2017($1.22)($1.19)($1.19)N/A
8/14/2017Q2 2017($0.57)($1.78)($1.78)N/A
6/16/2017Q1 2017($0.88)($1.74)($1.74)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 10/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.